All articles by  

1. EC approves GSK-Pfizer consumer health JV with conditions

   The European Commission (GSK) has cleared GlaxoSmithKline (GSK) and Pfizer’s proposed merger of respective consumer health businesses to create a…
   Read More…

   11 Jul
2. UK to test subscription payment model for antibiotics

   The UK Government has announced the trial of a subscription style payment system aimed at encouraging the development of new…
   Read More…

   10 Jul
3. BioNTech secures $325m in series B funding

   German company BioNTech has raised $325m in a series B financing round to support further development of its therapeutics pipeline…
   Read More…

   10 Jul
4. Jazz Pharmaceuticals buys oncology asset from Redx in $206m deal

   Jazz Pharmaceuticals has agreed to acquire a pre-clinical pan-RAF inhibitor programme from Redx Pharma intended for the treatment of certain…
   Read More…

   10 Jul
5. Evotec spin-off to develop cancer drugs using DDR pathway

   Evotec has formed spin-off company Breakpoint Therapeutics to focus on the development of its DNA damage response (DDR) portfolio. The…
   Read More…

   9 Jul
6. US judge blocks HHS rule to disclose drug prices in TV ads

   US District Judge Amit Mehta has blocked a Department of Health and Human Services (HHS) rule that would have mandated…
   Read More…

   9 Jul
7. Merck and Utah University find potential diabetes drug target

   Merck Research Laboratories and the University of Utah Health have shown that deactivation of the dihydroceramide desaturase 1 (DES1) enzyme…
   Read More…

   8 Jul
8. NICE recommends Pfizer’s dacomitinib for NSCLC patients

   The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Pfizer’s dacomitinib (Vizimpro) as a…
   Read More…

   8 Jul
9. Study finds common cold virus could help kill bladder cancer tumours

   A study by the University of Surrey and Royal Surrey County Hospital in the UK has demonstrated that a strain…
   Read More…

   5 Jul
10. Nosopharm and Evotec to develop antibiotic drugs

    Nosopharm has partnered with German drug discovery and development firm Evotec to advance NOSO-502 into clinical development. NOSO-502 is an odilorhabdin…
    Read More…

    5 Jul